Brighton Marine Inc. Announces $10 Million Investment to Help Prevent and End Veteran Homelessness
The announcement was made by Brighton Marine CEO Rosye B. Cloud at an event honoring longtime employee Derrick Hassell, who has served Brighton's Veterans and the broader community for over 47 years, by renaming its first Veterans Housing Building in his honor.
"Today, we honor an employee that embodies our values and demonstrates care and dignity to every resident and health plan beneficiary we serve," said Cloud. "The resources we will invest over the next five years will help prevent housing insecurity and address the immediate needs of Veterans experiencing homelessness."
The commitment is part of Brighton Marine's Vision 2030 initiative, which was originally announced at the 2024 National Coalition for Homeless Veterans conference. The funds will be used to support:
Brighton Marine's master leasing program in Massachusetts , which makes affordable housing more accessible to Veterans and their families who might not qualify for other housing programs.
Emergency assistance through Brighton Marine's Empowerment Fund , which provides emergency funding to help prevent eviction or financial distress that could lead to homelessness.
The establishment of a prevention hub in Washington, D.C. to serve as an incubator for innovative programs and ideas that can help address Veteran homelessness and housing insecurity nationwide.
"No veteran should ever be without a safe, stable place to call home or the services that they need," said Massachusetts Governor Maura Healey, who also spoke at the event. "That's why in Massachusetts, we have prioritized ending Veteran homelessness for good and expanding resources and services for our heroes. Organizations like Brighton Marine are critical partners in this work, and we thank them for their investment to create this beautiful campus that will provide essential housing, health care and other services for local veterans."
According to the U.S. Department of Housing and Urban Development's Annual Homelessness Assessment Report, as of December 2024 there were 550 Veterans experiencing homelessness in Massachusetts. Homelessness can cause a myriad of health concerns, ranging from a lack of access to basic hygiene and increased risk of contracting infectious disease to more profound barriers to accessing vital health care and other services.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
GCC Healthcare Market Projections: Opportunities from 2024 to 2030
Explore the future of GCC healthcare with this comprehensive report, analyzing the sector's growth from 2024 to 2030. Gain insights into national strategies like Vision 2030, policy reforms, AI, digital health, and investment opportunities across Saudi Arabia, UAE, Qatar, Kuwait, Oman, and Bahrain. GCC Healthcare Innovation Market Dublin, Aug. 18, 2025 (GLOBE NEWSWIRE) -- The "Healthcare Innovation in the GCC" report has been added to report provides an analysis of the healthcare landscape in the Gulf Cooperation Council (GCC) countries. The report estimates the Total Addressable Market (TAM) for the GCC healthcare sector from 2024 to 2030, offering country-specific projections. This analysis provides critical insights into the commercial potential and investment opportunities in the region's rapidly evolving healthcare ecosystem. The countries included in the analysis are Saudi Arabia, the United Arab Emirates (UAE), Qatar, Kuwait, Oman, and Bahrain. A key focus of the report is the evaluation of government policies aimed at strengthening the healthcare sector. This includes assessing each country's commitment to enhancing healthcare infrastructure, expanding the healthcare workforce, and increasing public and private healthcare spending. The analysis highlights how national strategies such as Vision 2030 are driving systemic transformation within the sector. The report incorporates the latest available data, including figures on the number of hospitals, hospital beds, and specialized medical staff, with most datasets available up to study further examines the scale and diversity of healthcare infrastructure in the region, covering the number of hospitals, the development of specialized facilities, and the emergence of local biotech and pharmaceutical companies. It also highlights investment-friendly regulations and policy reforms that are fostering a favorable business environment for domestic and foreign emerging trends are explored, including the growing adoption of artificial intelligence (AI), digital health platforms, electronic medical records, telemedicine, and other smart healthcare technologies. These innovations are pivotal in improving service delivery, patient outcomes, and system analysis provides critical insights into the commercial potential and investment opportunities in the region's rapidly evolving healthcare study is intended to serve as a strategic resource for policymakers, investors, healthcare providers, technology firms, and research institutions. It will equip these groups with a detailed framework to understand the sector's growth trajectory, partnership potential, and innovation report includes: An analysis of innovation in healthcare technologies in the GCC (Gulf Cooperation Council) countries Analyses of the GCC market trends, with revenue data for 2024, estimates for 2025, and projected CAGRs through 2030 Estimates of the size and revenue prospects of the GCC healthcare market, and a corresponding share analysis by sector (care settings), application and emerging countries Facts and figures pertaining to the current market dynamics, technological advances, regulations and the impact of macroeconomic factors Analysis of the industry structure, including companies' product offerings, strategic alliances, venture fundings and investment outlook Key Attributes: Report Attribute Details No. of Pages 56 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $121.9 Billion Forecasted Market Value (USD) by 2030 $170.5 Billion Compound Annual Growth Rate 5.9% Regions Covered Middle East Key Topics Covered: Chapter 1 Executive Summary Market Outlook Scope of Report Reasons for Doing this Study Market Summary Chapter 2 GCC Healthcare Industry Outlook SWOT Analysis of the GCC Healthcare Industry Pestle Analysis of GCC Healthcare Industry Chapter 3 Market Dynamics Market Drivers High Prevalence of Non-Communicable Diseases Growing Investments and Funding in the GCC Region Economic Growth in the GCC Region Market Restrains Higher Dependence on Imports of Healthcare Products Shortage of Healthcare Professionals Market Opportunities Increasing Focus on Medical Tourism in the GCC Expansion of AI and Digital Healthcare Solutions Chapter 4 Saudi Arabia Healthcare Industry Outlook Market Size Analysis Healthcare Expenditure Overview Country Healthcare Infrastructure Overview Healthcare Innovation Overview Chapter 5 United Arab Emirates (UAE) Healthcare Industry Outlook Chapter 6 Kuwait Healthcare Industry Outlook Chapter 7 Oman Healthcare Industry Outlook Chapter 8 Qatar Healthcare Industry Outlook Chapter 9 Bahrain Healthcare Industry Outlook Chapter 10 Concluding Remarks and Recommendations Recommendations for Strengthening Healthcare Innovation and Collaboration in the GCC For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment GCC Healthcare Innovation Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
Yahoo
an hour ago
- Yahoo
How 9 minutes of daily HIIT may improve kids' brain function and learning, according to research
When you buy through links on our articles, Future and its syndication partners may earn a commission. Kids' attention spans aren't exactly getting any longer. Some can't even make it to the end of a 10-second TikTok without swiping away. To be honest, I'm also guilty of this sometimes. But if you can hold their focus for nine whole minutes of exercise, scientists think they've found a little hack that could help children concentrate better in class. Researchers from the University of Eastern Finland studied how short bursts of physical activity could influence a child's ability to focus. They asked seven- to 13-year-olds to complete a simple nine-minute workout before sitting down to cognitive tests. The results? Kids who exercised performed better on tasks that required sustained attention and working memory compared to those who stayed seated. If you are a parent looking to move more and encourage your children to do the same, our guide to the best fitness trackers can help you keep track of your activity levels and stay motivated. What kind of exercise did the study use? The study found that nine minutes of high-intensity interval exercise (HIIE) can help children focus better and improve performance on cognitive tasks. For reference, this activity took place in a school setting before tests. The researchers suggest the boost in focus may come from the temporary increase in heart rate and blood flow, which delivers more oxygen and nutrients to the brain, along with the release of neurotransmitters that support alertness and cognitive function. If you are a parent and want to try using this at home to help your child focus, settle down after school, or tackle homework more easily, the principle is pretty flexible. You don't need a full PE class. Just nine minutes of fun, energetic high-intensity interval exercise (HIIE) that gets your child's heart rate up could make a difference. This could be a quick dance to a favorite song or two, a short obstacle course in the living room, or a few laps around the yard. It's important to note that this research does not provide a guaranteed solution for improving focus in all children, and every child's needs and circumstances are different. The study shows a potential benefit in a classroom setting, but individual results may vary. Still, making exercise a fun and regular part of family life can support both the body and mind. Follow Tom's Guide on Google News to get our up-to-date news, how-tos, and reviews in your feeds. Make sure to click the Follow button. More from Tom's Guide Here are 7 ways I get the most out of my Garmin watch when training for a race I do this quick chair exercise every day to beat back pain and strengthen my core while I work Forget running — I added power walking intervals to my walks and now I'm hooked Solve the daily Crossword
Business Wire
an hour ago
- Business Wire
Anocca Raises SEK 440 Million to Advance Clinical Trial Targeting Pancreatic Cancer
SÖDERTÄLJE, Sweden--(BUSINESS WIRE)--Anocca AB ('Anocca' or the 'Company'), a leading clinical-stage T-cell immunotherapy company, has successfully raised SEK ~440 million (USD ~46 million) in financing. The additional capital will be used to drive the continued progress of VIDAR-1, Anocca's gene-edited TCR-T cell therapies targeting mutant KRAS in pancreatic cancer, through early-stage clinical development, as well as progress Anocca's preclinical pipeline. The financing was led by Mellby Gård with strong support from AMF, Ramsbury and existing shareholders, alongside new investors. Recruitment is now open for Phase I of the multi-centre trial of VIDAR-1, which is being conducted at leading university hospitals across Sweden, Denmark, Germany and The Netherlands. Reagan Jarvis, co-founder and Chief Executive Officer of Anocca, said: 'We thank our investors for their strong and continued support as we advance our first TCR-T cell therapy products into the clinic. The team has built a unique discovery platform and in-house manufacturing capability, and we are now excited to see the first products reaching patients with high unmet need.' Johan Andersson, Chairman of Mellby Gård, commented: 'We have been invested in Anocca throughout its preclinical development and are pleased to see the Company transition into a clinical stage biotech. We look forward to seeing Anocca help patients that have limited treatment options today with their innovative approach to T-cell therapies.' SEB Corporate Finance acted as financial advisor to Anocca on the finalisation of the transaction, and Mannheimer Swartling and HWF Advokater have acted as legal advisors. ENDS About Anocca Anocca is a fully integrated clinical-stage biopharmaceutical company that develops libraries of T-cell receptor-engineered T cell (TCR-T) therapies to redefine the treatment of solid tumours and other difficult to treat diseases, including infectious and autoimmune diseases. The company has built a unique discovery engine that uses programmable human cells to recreate and manipulate T cell immunity. These proprietary technologies enable scaling of TCR-T cell therapy development, allowing the systematic generation of libraries of products that represent personalised treatments for the broad patient populations. Anocca currently has the broadest pipeline of TCR-T oncology cell therapy treatments. Anocca operates an advanced research and development infrastructure, underpinned by a custom software ecosystem, AnoccaOS, and an in-house cGMP manufacturing and process development facility. Anocca's TCR-T cell therapies are novel discoveries from its platform and manufactured using non-viral gene editing technology at Anocca's facilities in Södertälje, Sweden. 130+ staff from 40+ nations work at Anocca. About the VIDAR-1 clinical programme VIDAR-1 is designed as a multi-product umbrella trial targeting oncogenic driver mutations in KRAS within pancreatic ductal adenocarcinoma (PDAC). It will investigate up to 20 patients per product in a set of phase I/II studies. Phase I is currently conducted at eight sites in four countries with additional countries and sites in phase II. Patients will be eligible to enrol if they have an HLA, and KRAS mutation, matching an available product. More information about the clinical trial can be found at the EU's clinical trials website. About KRAS and PDAC Mutant KRAS is implicated in pancreatic, lung and colorectal cancers. G12V and G12D mutations in KRAS affect around 90% of pancreatic cancer patients. The five-year survival rate of patients with PDAC is less than 10% (1). Despite recent advances there are no definitive treatments for advanced patients at present (2). References 1. Rawla et al (2019). Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 10(1):10–27. doi: 10.14740/wjon1166 2. Hu & O'Reilly (2023). Therapeutic developments in pancreatic cancer. Nat Rev Gastroenterol Hepatol 21, 7–24. doi: 10.1038/s41575-023-00840-w
